Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Glaucoma · Macular Edema

Allergan Pharmaceuticals International

Allergan Pharmaceuticals International Limited

Allergan Pharmaceuticals International patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Dublin, IE HQ
EMA registrant Type
Company details
Status
Public
HQ
Dublin, IE
Programs
13
Drugs
15
Patents
25
All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Allergan Pharmaceuticals International patents

25 pharmaceutical patents indexed for Allergan Pharmaceuticals International. 0 expire within 24 months.

Allergan Pharmaceuticals International has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

25 patents

Patent portfolio

  1. US 12383545

    TREATMENT OF MIGRAINE

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 2025064788

    TREATMENT OF MIGRAINE

    Expires Wed Feb 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 2024180883

    TREATMENT OF MIGRAINE

    Expires Wed Jun 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2024081718

    ANTAGONISTE DU RÉCEPTEUR CGRP POUR LE TRAITEMENT DE LA MIGRAINE

    Expires Wed Apr 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. CA 3244873

    TRAITEMENT PRÉVENTIF DE LA MIGRAINE

    Expires Wed Sep 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2023077094

    TRAITEMENT D'UN TROUBLE DÉPRESSIF MAJEUR

    Expires Wed Apr 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 2023130736

    METHODS OF TREATING MIGRAINE

    Expires Wed Apr 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 2022380379

    PHARMACEUTICAL COMPOUNDS

    Expires Wed Nov 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 2022193051

    TREATMENT OF MIGRAINE

    Expires Wed Jun 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 2022031686

    Treatment of Migraine

    Expires Wed Jan 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 2021387969

    BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 AND/OR M4 RECEPTOR AGONISTS

    Expires Wed Dec 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. CA 3177686

    COMPOSITIONS COMPRENANT DE LA TROPOELASTINE RETICULEE A DE L'ACIDE HYALURONIQUE ET LEURS PROCEDES D'UTILISATION

    Expires Wed Nov 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. CA 3156009

    POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP

    Expires Wed Mar 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. CA 3152006

    TROPOELASTINE DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DE LA CICATRISATION DE L'ACNE

    Expires Wed Feb 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. WO 2021005494

    ANTAGONISTES DU CGRP ET DÉRIVÉS DE CLOSTRIDIALES POUR LE TRAITEMENT DE TROUBLES NEUROPSYCHIATRIQUES ET NEUROLOGIQUES

    Expires Wed Jan 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. WO 2021005497

    ANTAGONISTES DU CGRP ET DÉRIVÉS DE CLOSTRIDIUM POUR LE TRAITEMENT DE TROUBLES ASSOCIÉS À LA DÉPRESSION CORTICALE ENVAHISSANTE

    Expires Wed Jan 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2021005493

    ANTAGONISTES DU CGRP ET TOXINES BOTULINIQUES POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES ET NEUROLOGIQUES

    Expires Wed Jan 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 2020345623

    METHODS OF SCAR PREVENTION AND/OR TREATMENT

    Expires Wed Oct 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. CA 3133787

    GELS HOMOGENES INJECTABLES COMPRENANT DE MULTIPLES FORMES D'ACIDE HYALURONIQUE ET LEURS PROCEDES DE FABRICATION

    Expires Wed Sep 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2020012244

    TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AU MOYEN DE BRAZIKUMAB

    Expires Wed Jan 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. CA 3105778

    POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP ET DES DERIVES DE CLOSTRIDIUM

    Expires Wed Jan 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 2019374520

    TREATMENT OF MIGRAINE

    Expires Wed Dec 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 2019374518

    TREATMENT OF MIGRAINE

    Expires Wed Dec 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. CA 3091946

    EXPANSION ET DIFFERENCIATION DE CELLULES SOUCHES

    Expires Thu Sep 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. WO 2019016609

    TRAITEMENT DE LÉSIONS NON INFLAMMATOIRES

    Expires Wed Jan 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Allergan Pharmaceuticals International have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Allergan Pharmaceuticals International patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.